These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8779278)

  • 41. [Unproductive substrate binding as one aspect of substrate specificity of cholinesterases of different adhesiveness].
    Rozengart EV; Basova NE
    Zh Evol Biokhim Fiziol; 2003; 39(5):410-5. PubMed ID: 14689727
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative study of substrate and inhibitory specificity of monoamine oxidase in the optic ganglia of squids].
    Iagodina OV
    Zh Evol Biokhim Fiziol; 2010; 46(3):191-7. PubMed ID: 20583578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Phosphorus atom availability and mechanism enzyme inhibiting effect of organophosphorous inhibitors of cholinesterases of various origin. Results of conformational and correlational analysis].
    Rozengart EV; Shestakova NN; Prokator SO; Basova NE
    Zh Evol Biokhim Fiziol; 1999; 35(1):36-9. PubMed ID: 10399821
    [No Abstract]   [Full Text] [Related]  

  • 44. [About mechanism of interaction of phosphororganic inhibitors with cholinesterases of different origin].
    Rozengart EV; Basova NE; Suvorov AA
    Zh Evol Biokhim Fiziol; 2002; 38(3):208-13. PubMed ID: 12325259
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanism of unproductive binding of cholinesterase substrates.
    Rozengart EV; Basova NE; Suvorov AA
    Dokl Biochem Biophys; 2009; 429():315-9. PubMed ID: 20101828
    [No Abstract]   [Full Text] [Related]  

  • 46. [Species variability in the substrate-inhibitor specificity of cholinesterases from optical ganglia of the squid of the Gonatidae family].
    Rozengart EV; Basova NE
    Zh Evol Biokhim Fiziol; 2000; 36(3):188-91. PubMed ID: 11075437
    [No Abstract]   [Full Text] [Related]  

  • 47. [Application of bisalkaloid derivatives of dicarboxylic acids based on lupinine, anabasine and cytisine as cholinesterase inhibitors of various origin].
    Rozengart EV; Basova NE
    Zh Evol Biokhim Fiziol; 2004; 40(4):305-10. PubMed ID: 15481367
    [No Abstract]   [Full Text] [Related]  

  • 48. [Ephedrine derivatives as substrates and inhibitors of cholinesterases].
    Abduvakhabov AA; Khakimov IuR; Maĭzel' EB; Rozengart EV; Sadykov AA
    Dokl Akad Nauk SSSR; 1978; 241(1):227-30. PubMed ID: 679804
    [No Abstract]   [Full Text] [Related]  

  • 49. Conformational characteristics of the structure of acetylcholine amide derivatives and the specificity of their action as reversible inhibitors of cholinesterases of different animals.
    Rozengart EV; Basova NE
    Dokl Biochem Biophys; 2005; 405():450-3. PubMed ID: 16480150
    [No Abstract]   [Full Text] [Related]  

  • 50. Element-onium silatran derivatives as reversible inhibitors of cholinesterases of various origin.
    Rozengart EV; Basova NE
    Dokl Biochem Biophys; 2005; 405():400-5. PubMed ID: 16480137
    [No Abstract]   [Full Text] [Related]  

  • 51. [COMPARATIVE SENSITIVITY OF CHOLINESTERASES IN VERTEBRATES AND INVERTEBRATES TO HIGHLY SPECIFIC ORGANOPHOSPHORUS INHIBITORS DIISOPROPYL FLUOROPHOSPHATE (DFP) AND (2-ETHOXYMETHYL PHOSPHORYL THIOETHYL) ETHYL (METHYL) SULPHONIUM SULPHOMETHYLAT (GD-42)].
    Basova NE; Kormilitsyn BN; Perchenok AY; Rozengart EV; Saakov VS; Suvorov AA
    Zh Evol Biokhim Fiziol; 2015; 51(6):419-26. PubMed ID: 26983276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Conformational aspects of substrate specificity of cholinesterases of various origin].
    Rozengart EV; Shestakova NN; Basova NE; Khovanskikh AE
    Dokl Akad Nauk; 1999 May; 366(2):266-8. PubMed ID: 10495918
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanisms of cholinesterase inhibition by inorganic mercury.
    Frasco MF; Colletier JP; Weik M; Carvalho F; Guilhermino L; Stojan J; Fournier D
    FEBS J; 2007 Apr; 274(7):1849-61. PubMed ID: 17355286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Spectral study of the peripheral site of ligand binding in the active center of cholinesterases from different natural sources].
    Gaĭnulina ET; Karavaeva VA; Kliuster OV; Ryzhikov SB
    Izv Akad Nauk Ser Biol; 2006; (3):292-6. PubMed ID: 16771142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of quaternary ammonium compounds on the hydrolysis of various substrates that is catalyzed by specific and nonspecific cholinesterases].
    Kupriianov VA; Kulikova AI; Rozengart VI
    Ukr Biokhim Zh; 1973; 45(1):70-5. PubMed ID: 4697110
    [No Abstract]   [Full Text] [Related]  

  • 56. Variability of the structure of the cholinesterase active center as studied by factor analysis.
    Moralev SN
    Dokl Biochem; 2000; 373(1-6):156-8. PubMed ID: 11002849
    [No Abstract]   [Full Text] [Related]  

  • 57. [A comparative study of the cholinesterase and carboxylesterase sensitivities of mammals and arthropods to new phenyl and glycidyl esters of dialkyl thiophosphoric acid].
    Brestkin AP; Kormilitsyn BN; Kugusheva LI; Maĭzel' EB; Moralev SN; Mukanova KD; Khovanskikh AE; Abduvakhabov AA; Babaev BN; Dalimov DN
    Zh Evol Biokhim Fiziol; 1996; 32(4):377-83. PubMed ID: 9054171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. QSAR, docking, dynamic simulation and quantum mechanics studies to explore the recognition properties of cholinesterase binding sites.
    Correa-Basurto J; Bello M; Rosales-Hernández MC; Hernández-Rodríguez M; Nicolás-Vázquez I; Rojo-Domínguez A; Trujillo-Ferrara JG; Miranda R; Flores-Sandoval CA
    Chem Biol Interact; 2014 Feb; 209():1-13. PubMed ID: 24321698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Guanidine derivatives as reversible inhibitors of cholinesterases of various origins: conformation and complex forming].
    Rozengart EV; Basova NE; Zhorov BS; Moralev SN; Saakov VS; Suvorov AA; Khovanskikh AE
    Zh Evol Biokhim Fiziol; 2003; 39(4):313-22. PubMed ID: 14520894
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
    Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
    Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.